Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $218B | +$1.09B | 202 | 3.27% | Increased |
|
| 2 |
BlackRock
New York
| $188B | +$522M | 202 | 3.3% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $95.8B | +$37.9M | 187 | 3.32% | Increased |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $48.9B | -$340M | 215 | 3.12% | Reduced |
|
| 5 |
JP Morgan Chase
New York
| $44.2B | +$1.71B | 177 | 2.65% | Increased |
|
| 6 |
Morgan Stanley
New York
| $40.3B | +$1.28B | 215 | 2.44% | Increased |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $36.7B | -$3.5B | 164 | 1.91% | Reduced |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $30.6B | -$1.79B | 127 | 3.27% | Reduced |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $25.5B | -$2.41B | 62 | 4.46% | Reduced |
|
| 10 |
Bank of America
Charlotte,
North Carolina
| $25B | +$578M | 227 | 1.69% | Increased |
|
| 11 |
Northern Trust
Chicago,
Illinois
| $23B | -$261M | 186 | 2.95% | Reduced |
|
| 12 |
Bank of New York Mellon
New York
| $22.1B | -$1.66B | 151 | 3.97% | Reduced |
|
| 13 |
Invesco
Atlanta,
Georgia
| $20.9B | -$150M | 127 | 3.29% | Reduced |
|
| 14 |
Massachusetts Financial Services
Boston,
Massachusetts
| $18.3B | -$1.18B | 50 | 5.66% | Reduced |
|
| 15 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $16.7B | -$676M | 56 | 10.23% | Reduced |
|
| 16 |
Capital Research Global Investors
Los Angeles,
California
| $16.7B | -$2.03B | 17 | 3.14% | Reduced |
|
| 17 |
Goldman Sachs
New York
| $16.1B | -$48.2M | 163 | 1.97% | Reduced |
|
| 18 |
Charles Schwab
San Francisco,
California
| $15.8B | +$290M | 148 | 2.53% | Increased |
|
| 19 |
Franklin Resources
San Mateo,
California
| $15.6B | +$577M | 108 | 3.9% | Increased |
|
| 20 |
UBS AM
Chicago,
Illinois
| $15.3B | -$3.57B | 91 | 3.33% | Reduced |
|
| 21 |
Dimensional Fund Advisors
Austin,
Texas
| $15.1B | +$518M | 126 | 3.24% | Increased |
|
| 22 |
Legal & General Group
London,
United Kingdom
| $14.5B | +$539M | 141 | 3.25% | Increased |
|
| 23 |
Capital International Investors
Los Angeles,
California
| $14.1B | +$1.11B | 13 | 2.28% | Increased |
|
| 24 |
UBS Group
Zurich,
Switzerland
| $12.5B | +$745M | 229 | 1.96% | Increased |
|
| 25 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $12.4B | +$979M | 176 | 2.04% | Increased |
|